References
- 1. Hiramoto JS, Teraa M, de Borst GJ, Conte MS. Interventions for lower extremity peripheral artery disease Nature Reviews Cardiology. 2018;15:332–350.10.1038/s41569-018-0005-0
- 2. Zipes D, Libby P. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 11th edition; 2018.
- 3. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39:763–821.10.1093/eurheartj/ehx095
- 4. Aboyans V, Ricco JB, Bartelink MeL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) – Web Addenda. European Heart Journal.2017; 00:1–22. doi:10.1093/eurheartj/ehx095.10.1093/eurheartj/ehx095
- 5. Boudi FB, Yasmine S. Risk Factors for Coronary Artery Disease: https://emedicine.medscape.com/article/164163-overview#a3 Mar 30, 2020.
- 6. Fowker FG, RudanD, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systemic review and analysis. Lancet. 2013;382:1329-1340.10.1016/S0140-6736(13)61249-0
- 7. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291-7.10.1056/NEJMoa00341711794147
- 8. Emdin CA, Anderson SG, Callender T et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ 2015; 351:h4865.10.1136/bmj.h4865458646226419648
- 9. Joosten MM, Pai JK, Bertoia ML, Rimm EB et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308:1660–1667.10.1001/jama.2012.13415373310623093164
- 10. Rea TD, Heckbert Sr, Kaplan RC et al. Smoking status and riskfor recurrent coronary events after myocardial infaction. Ann Intern Med. Sep 17 2002;137(6):494-500.10.7326/0003-4819-137-6-200209170-00009
- 11. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481–2485.10.1001/jama.285.19.248111368701
- 12. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509–152.10.1161/CIRCRESAHA.116.30384925908725
- 13. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–965.10.1067/mhj.2002.12287112075249
- 14. Howard BV, Rodriguez BL, Bennett PH et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: epidemiology. Circulation. 2002; 105(18):e132-710.1161/01.CIR.0000013953.41667.09
- 15. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154.10.1161/01.CIR.0000095676.90936.8014581387
- 16. Garimella PS, Hirsch AT, Peripheral Artery Disease and Chronic Kidney Disease: Clinical Synergy to Improve Outcomes. Adv Chronic Kidney Dis. 2014 Nov; 21(6):460–471. doi: 10.1053/j.ackd.2014.07.005.10.1053/j.ackd.2014.07.005425447025443571
- 17. Chuang YW, Yu MC, Lin CL, Yu TM, Shu KH, Huang ST, Kao CH. Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study. Thromb Haemost 2016;115:439–445.10.1160/th15-07-0600